These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38452707)

  • 1. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
    Agrawal T; Maddileti S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.
    Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
    Deng X; Iwagawa T; Fukushima M; Watanabe S
    Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two H1 hESC sublines carrying deletions of RB1 exon 1/promoter in heterozygous or compound heterozygous state.
    Menges J; Cremanns M; Steenpass L
    Stem Cell Res; 2019 Aug; 39():101517. PubMed ID: 31404748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
    Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
    Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.
    Avior Y; Lezmi E; Yanuka D; Benvenisty N
    Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RB1 in human embryonic stem cell-derived retinal organoids.
    Zheng C; Schneider JW; Hsieh J
    Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
    Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
    Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids.
    Vincent A; Krishnakumar S; Parameswaran S
    Mol Biol Rep; 2024 May; 51(1):606. PubMed ID: 38704498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational screening of germline
    Nguyen HH; Nguyen HTT; Vu NP; Le QT; Pham CM; Huyen TT; Manh H; Pham HLB; Nguyen TD; Le HTT; Van Nong H
    Mol Vis; 2018; 24():231-238. PubMed ID: 29568217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of two induced pluripotent stem cell lines from conjunctiva of a retinoblastoma patient.
    Xu P; Guo F; Xiao W; Wang Y; Ye K; Mao Y; Zhong X
    Stem Cell Res; 2023 Oct; 72():103200. PubMed ID: 37708614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
    Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
    Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
    Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
    Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of mutations in the
    Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
    Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
    Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel insights into RB1 mutation.
    Yao Y; Gu X; Xu X; Ge S; Jia R
    Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating RB1 predictive value in clinical cancer therapy: Are we there yet?
    Indovina P; Pentimalli F; Conti D; Giordano A
    Biochem Pharmacol; 2019 Aug; 166():323-334. PubMed ID: 31176618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of germline
    Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
    Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular alterations in retinoblastoma beyond RB1.
    Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
    Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
    Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
    Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.